We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+7.2%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.86B
AUM Growth
+$1.56B
(+68%)
Cap. Flow
+$1.56B
Cap. Flow
% of AUM
40.55%
Top 10 Holdings %
Top 10 Hldgs %
59.92%
Holding
107
New
12
Increased
23
Reduced
24
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scorpio Tankers
STNG
|
+$132M |
| 2 |
Cameco
CCJ
|
+$117M |
| 3 |
Vistra
VST
|
+$57M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$46.5M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$44.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
New Fortress Energy
NFE
|
+$71.4M |
| 2 |
WillScot Mobile Mini Holdings
WSC
|
+$56.1M |
| 3 |
Noble Corp
NE
|
+$52M |
| 4 |
Valaris
VAL
|
+$41.1M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$34.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.36% |
| 2 | Energy | 12.76% |
| 3 | Industrials | 9.71% |
| 4 | Financials | 6.9% |
| 5 | Technology | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arbutus Biopharma
ABUS
$907M
| $12.7M | 0.33% |
4,195,072
+728,791
| +21% | +$2.06M |
|
52
Telesat
TSAT
$934M
| $12.1M | 0.31% |
1,410,000
| – | – |
|
53
Nerdy
NRDY
$93.7M
| $10.9M | 0.28% |
2,601,118
-849,288
| -25% | -$2.6M |
|
54
Trevi Therapeutics
TRVI
$2.53B
| $10.5M | 0.27% |
5,684,420
| – | – |
|
55
RadNet
RDNT
$6.06B
| $10.1M | 0.26% |
+405,419
| New | +$8.82M |
|
56
FTAI Infrastructure
FIP
$533M
| $9.58M | 0.25% |
3,193,530
| – | – |
|
|
57
Noble Corp
NE
$7.04B
| $9.39M | 0.24% |
237,875
-1,298,547
| -85% | -$52M |
|
|
CMRX
58
DELISTED
Chimerix, Inc.
CMRX
| $9.24M | 0.24% |
7,336,735
-163,265
| -2% | -$266K |
|
|
MREO
59
Mereo BioPharma
MREO
$48.3M
| $7.33M | 0.19% |
10,366,120
| – | – |
|
60
PLAYSTUDIOS Inc
MYPS
$72.1M
| $7.24M | 0.19% |
1,961,184
| – | – |
|
61
Cullinan Oncology
CGEM
$1.26B
| $6.41M | 0.17% |
626,929
| – | – |
|
62
Werewolf Therapeutics
HOWL
$18.6M
| $5.03M | 0.13% |
1,935,357
+99,970
| +5% | +$298K |
|
63
TherapeuticsMD
TXMD
$24.1M
| $4.47M | 0.12% |
1,192,191
-565,000
| -32% | -$2.71M |
|
|
BCYC
64
Bicycle Therapeutics
BCYC
$284M
| $4.37M | 0.11% |
+205,423
| New | +$5.15M |
|
65
Tarsus Pharmaceuticals
TARS
$3.07B
| $2.78M | 0.07% |
221,488
-63,244
| -22% | -$925K |
|
66
Cellebrite
CLBT
$3.8B
| $2.49M | 0.06% |
408,192
-220,828
| -35% | -$1.2M |
|
|
VIRX
67
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.36M | 0.06% |
1,487,385
+156,402
| +12% | +$284K |
|
|
FREE
68
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $2.32M | 0.06% |
905,880
-92,483
| -9% | -$316K |
|
|
SCTL
69
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.28M | 0.03% |
1,076,587
| – | – |
|
70
Xeris Biopharma Holdings
XERS
$1.55B
| $695K | 0.02% |
+426,267
| New | +$534K |
|
|
VINC
71
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $402K | 0.01% |
19,336
| – | – |
|
72
Advantage Solutions
ADV
$399M
| – | – |
-14,403
| Closed | -$749K |
|
73
PUT
AMC Entertainment Holdings
AMC
$2.26B
| – | – |
-206,290
| Closed | -$8.4M |
|
74
AtaiBeckley Inc
ATAI
$2.68B
| – | – |
-1,319,137
| Closed | -$3.51M |
|
75
Bausch Health
BHC
$2.32B
| – | – |
-4,052,945
| Closed | -$25.5M |
|
Similar funds
RCM
SIM
NPT
AC
PVI
WPL
LAMI
CCMT
Rubric Capital Management (New York)'s Q1 2023 Portfolio in Review
As of Q1 2023, Rubric Capital Management (New York) held 107 positions worth $3.86B, up 68% from $2.29B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Rubric Capital Management (New York) deployed $1.56B of net new capital in Q1 2023, opening 12 new positions and adding to 23 existing holdings. Its largest new stake was Scorpio Tankers: 2,404,567 shares worth $135M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 27% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Noble Corp, an estimated $52M trimmed.
- Rubric Capital Management (New York)'s largest Q1 2023 buy was Scorpio Tankers: 2,404,567 shares worth $135M.
- Rubric Capital Management (New York) added most to Cameco in Q1 2023, an estimated $117M increase.
- Rubric Capital Management (New York)'s biggest Q1 2023 reduction was Noble Corp, cutting an estimated $52M.
- Rubric Capital Management (New York) fully exited New Fortress Energy in Q1 2023, selling an estimated $71.4M.
- Rubric Capital Management (New York)'s ten largest holdings make up 60% of its $3.86B portfolio in Q1 2023.
- Rubric Capital Management (New York) opened 12 new positions and closed 36 in Q1 2023.
- Rubric Capital Management (New York)'s portfolio value rose 68% quarter-over-quarter to $3.86B.
Based on Rubric Capital Management (New York)'s 13F filing for Q1 2023, filed 12 May 2023.